Mantle Cell Lymphoma

Showing 26 - 50 of 267

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

CLL/SLL, NHL, Mantle Cell Lymphoma Trial in United States (SYNCAR-001, STK-009, Cyclophosphamide)

Recruiting
  • CLL/SLL
  • +6 more
  • Duarte, California
  • +4 more
Jan 12, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

Active, not recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

Completed
  • Multiple Myeloma
  • +11 more
  • Pre-biotic foods/drinks
  • Charlottesville, Virginia
    University of Virginia
Jan 2, 2023

Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

Recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Duarte, California
  • +23 more
Dec 28, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

Completed
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Determination of COVID-19 vacciantion efficacy
  • Rouen, France
    Centre Henri Becquerel
Dec 22, 2022

Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

Recruiting
  • Mantle Cell Lymphoma
  • New Orleans, Louisiana
  • +5 more
Dec 13, 2022

B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy Trial (CTX112)

Not yet recruiting
  • B-cell Lymphoma
  • +7 more
  • CTX112
  • (no location specified)
Dec 12, 2022

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
Dec 7, 2022

The Role of 18F-FDG-PET for Staging and Prognostication

Recruiting
  • Mantle Cell Lymphoma
    • Reggio Calabria, Calabria, Italy
    • +30 more
    Dec 5, 2022

    Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Nov 22, 2022

    Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
    • Basking Ridge, New Jersey
    • +4 more
    Dec 1, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +16 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 1, 2022

    Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

    Recruiting
    • Mantle Cell Lymphoma
    • +9 more
    • L-Bcl-2 antisense oligonucleotide
    • Augusta, Georgia
    • +2 more
    Nov 18, 2022

    Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

    Active, not recruiting
    • Acute Leukemia
    • +14 more
    • Duarte, California
      City of Hope Medical Center
    Nov 18, 2022

    Mantle Cell Lymphoma Trial in United States (Venetoclax, Bendamustine, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Urbana, Illinois
    • +9 more
    Nov 10, 2022

    B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial (BN301)

    Not yet recruiting
    • B-cell Lymphoma
    • +4 more
    • (no location specified)
    Nov 9, 2022

    Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

    Recruiting
    • Mantle Cell Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 1, 2022

    CCND1 Positive, Mantle Cell Lymphoma, t(11;14) Positive Trial in Atlanta, Johns Creek (Bendamustine, Obinutuzumab, Venetoclax)

    Active, not recruiting
    • CCND1 Positive
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Nov 2, 2022

    B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

    Not yet recruiting
    • B-cell Malignancy
    • +7 more
    • (no location specified)
    Oct 26, 2022